Sign up to receive 5 free days of our daily summary for tech news.

Read this article for free.

Already a subscriber? Log in here

Enterprise Startups Google

Inside the Gulf: The FDA vs. Silicon Valley

Federal regulators have begun to transform the way they evaluate new high-tech health products, but it would be difficult to know from talking to technology entrepreneurs.

The recent high-profile dust-up between genetic test maker 23andMe and the Food and Drug Administration reflects the growing divide between tech firms and regulators in Washington over the industry’s ability to market health-related devices to consumers. But behind the scenes, another story has been playing out, one where the FDA has moved to revamp its procedures for evaluating new devices even as regulators and technology companies remain far apart in their views on how to balance innovation with safety.

These differences could have a real impact on the growing group of companies trying to transform medicine through technology. The FDA’s approach is poorly understood by some entrepreneurs. Others have no patience for what they see as overzealous government meddling. Some tech companies strongly disapproved of the FDA’s recent decision to stop 23andMe from marketing genetic testing kits to consumers.

What Is The Information?

Notebook b5103017ee163370a1667c9ce59ab0ef023875a17888105d26c185cadf31bb69

Daily news analysis

Every weeknight, we'll send you our reporters’ views on the day’s top tech news—distilled into one email.

Notes bb3aa5069205d702dda37fc71dc6f1c59df2310c4379304e9f1199f052af4884

Exclusive Articles

We broke it first. Receive original reporting, stories, and exclusives you won't read anywhere else from the largest newsroom in tech.

Conference calls c9e664e8b96ee347d3e92b8309938f268422b9db98cfabca5c826fbb75054b23

Conference calls

Go deep into areas like crypto and VC diversity—or get real-time analysis of breaking news—via conference calls with our reporters and other experts.

Events 499acedd16cffc41445edd76bfd302b2836c2a27419890f17130a6b10e2aa3df

Special Events

For no extra fee, subscribers get access to more than a dozen events yearly, from intimate dinners to larger gatherings with marquee speakers.

Access the best reporting on the tech industry read by tens of thousands of global executives.

Become a contributor

Share your views and find other subscribers by completing your profile. You’ll be listed in our contributor directory.

Org Charts

Access the only collection of tech company org charts. Our expanding database includes companies like Amazon, Snap, and Uber.

Slack community

Discuss topics and current events with our subscriber-only Slack group and share news about your company with other subscribers.

Share with your team

Subscribers can unlock any article and share it with friends and co-workers through a special share link.

Stay up to date on Silicon Valley

Sign up for Jessica Lessin’s (The Information’s CEO & Founder) free Saturday newsletter and also receive a complimentary week of our daily afternoon tech commentary email.

Already a subscriber? Log in here

Recent Articles

Google Facebook

Why Product Doesn’t Win

By Jessica E. Lessin

Asia Google E-commerce

A Google Diaspora Shapes China’s Tech Scene

By Shai Oster

Enterprise Cloud

Microsoft Won’t Mess Up GitHub, Executive Says

By Kevin McLaughlin

Cybersecurity Facebook

Facebook On Hunt For Big Cybersecurity Acquisition

By Reed Albergotti and Sarah Kuranda

The 23andMe decision is the sort of thing that makes people in Silicon Valley talk about moving to a private island.